These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12417449)

  • 1. Brain-derived neurotrophic factor in patients with multiple sclerosis.
    Sarchielli P; Greco L; Stipa A; Floridi A; Gallai V
    J Neuroimmunol; 2002 Nov; 132(1-2):180-8. PubMed ID: 12417449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
    Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis.
    Sarchielli P; Orlacchio A; Vicinanza F; Pelliccioli GP; Tognoloni M; Saccardi C; Gallai V
    J Neuroimmunol; 1997 Dec; 80(1-2):76-86. PubMed ID: 9413261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis.
    Annunziata P; Pluchino S; Martino T; Guazzi G
    J Neuroimmunol; 1997 Jul; 77(1):128-33. PubMed ID: 9209277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission.
    Hollifield RD; Harbige LS; Pham-Dinh D; Sharief MK
    Autoimmunity; 2003 May; 36(3):133-41. PubMed ID: 12911279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
    Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
    Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
    Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
    Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
    Ehling R; Di Pauli F; Lackner P; Rainer C; Kraus V; Hegen H; Lutterotti A; Kuenz B; De Zordo T; Schocke M; Glatzl S; Löscher WN; Deisenhammer F; Reindl M; Berger T
    J Neuroimmunol; 2015 Oct; 287():98-105. PubMed ID: 26439969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Osztynowicz K; Kozubski W; Michalak S
    Neurol Neurochir Pol; 2018 Aug; 52(4):483-489. PubMed ID: 29643001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.
    Selmaj K; Nowak Z; Tchórzewski H
    Clin Exp Immunol; 1988 Jun; 72(3):428-33. PubMed ID: 2458871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor expression ex vivo in obesity.
    Huang CJ; Mari DC; Whitehurst M; Slusher A; Wilson A; Shibata Y
    Physiol Behav; 2014 Jan; 123():76-9. PubMed ID: 24140987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
    J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
    Mashayekhi F; Salehi Z; Jamalzadeh HR
    Acta Medica (Hradec Kralove); 2012; 55(2):83-6. PubMed ID: 23101271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF and Tau as biomarkers of severity in multiple sclerosis.
    Islas-Hernandez A; Aguilar-Talamantes HS; Bertado-Cortes B; Mejia-delCastillo GJ; Carrera-Pineda R; Cuevas-Garcia CF; Garcia-delaTorre P
    Biomark Med; 2018 Jul; 12(7):717-726. PubMed ID: 29865854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients.
    Patanella AK; Zinno M; Quaranta D; Nociti V; Frisullo G; Gainotti G; Tonali PA; Batocchi AP; Marra C
    J Neurosci Res; 2010 Apr; 88(5):1106-12. PubMed ID: 19885866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor.
    Chen M; Valenzuela RM; Dhib-Jalbut S
    J Neurol Sci; 2003 Nov; 215(1-2):37-44. PubMed ID: 14568126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.
    Gielen A; Khademi M; Muhallab S; Olsson T; Piehl F
    Scand J Immunol; 2003 May; 57(5):493-7. PubMed ID: 12753507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.